PMC:7305592 / 24795-26024 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7305592","sourcedb":"PMC","sourceid":"7305592","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7305592","text":"Next to negative aspects related to the treatment decision taken, many relatives also mentioned positive aspects. It was most frequently mentioned that it was positive the patient tried everything. Previously, we found that this was also an important aspect for the patients and oncologists (Mieras et al.: What goals do patients and oncologists have when starting a medical treatment for metastatic lung cancer?, submitted). Additionally, it was important for many relatives that the patients’ wish for treatment was followed, even when the relatives themselves felt that the treatment might have gone on for too long. Notably, none of the positive aspects we found resonated with aspects valued at the end of life found in a study by Steinhauser et al.: ‘pain and symptom management’, ‘clear decision making’, ‘preparation for death’ and ‘completion’ valued at the end of life [8]. This might be related to the fact that in our study we focused on the evaluation of the decision to start systemic treatment. For patients who start with treatment and their families, it might be more difficult to prepare for death than for people who do not start treatment. It might also be that they value the aspects at the end of life less.","tracks":[{"project":"2_test","denotations":[{"id":"32560645-10819707-13164272","span":{"begin":880,"end":881},"obj":"10819707"}],"attributes":[{"subj":"32560645-10819707-13164272","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#93eca4","default":true}]}]}}